Hirtle Callaghan & Co’s Geron GERN Stock Holding History

Hirtle Callaghan & Co’s Portfolio GERN Stock Details GERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-13,000	Closed	-$26K	–	588
2014 Q3	$26K	Buy	+13,000	New	+$32K	﹤0.01%	388

Other funds holding GERN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Hirtle Callaghan & Co's GERN Position: Q4 2014 in Review

Hirtle Callaghan & Co sold out of Geron (GERN) in Q4 2014, closing a stake of 13,000 shares — an estimated $26K sold.

Hirtle Callaghan & Co first reported a position in GERN in Q3 2014 and held it in 1 quarter. The position peaked at $26K in Q3 2014. 121 funds tracked by Wall St. Rank hold GERN as of Q4 2014.

Hirtle Callaghan & Co reported no remaining Geron position as of Q4 2014 after selling out during the quarter.
Hirtle Callaghan & Co sold 13,000 Geron shares in Q4 2014, an estimated $26K.
Hirtle Callaghan & Co first reported a position in Geron in Q3 2014 and held it in 1 quarter.
Hirtle Callaghan & Co's Geron position peaked at $26K in Q3 2014.
121 funds tracked by Wall St. Rank held Geron as of Q4 2014.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2014, filed 26 Jan 2015.